+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immunochemicals: Global Strategic Business Report

  • PDF Icon

    Report

  • 312 Pages
  • March 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4426701

Global Immunochemicals Market to Reach $6.4 Billion by 2030

The global market for Immunochemicals estimated at US$4.2 Billion in the year 2022, is projected to reach a revised size of US$6.4 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2022-2030. Catalog Antibodies, one of the segments analyzed in the report, is projected to record 4.6% CAGR and reach US$4.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Custom Antibodies segment is readjusted to a revised 6.9% CAGR for the next 8-year period.

The U.S. Market is Estimated at $1.2 Billion, While China is Forecast to Grow at 5.1% CAGR

The Immunochemicals market in the U.S. is estimated at US$1.2 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 5.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.7% and 4.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Select Competitors (Total 116 Featured) -

  • Abcam Plc.
  • Agilent Research Laboratories
  • Beckman Coulter GmbH
  • Biolegend Inc.
  • Bio-Rad Laboratories Inc.
  • Cell Signaling Technology Inc.
  • GenScript Biotech Corporation
  • PerkinElmer Inc.
  • Rockland Immunochemicals Inc.
  • Santa Cruz Biotechnology Inc.
  • Sigma-Aldrich Corporation
  • Thermo Fischer Scientific Inc.

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Immunochemicals - A Prelude
  • Recent Market Activity
  • Research Antibodies Market: Critical Role in Drug Discovery and Research
  • Key Factors Influencing Purchasing Decisions
  • Citations: One of the Key Factors Driving Research Antibodies’ Purchase
  • The US Dominates the Global Immunochemicals Market
  • Emerging Markets Offer Huge Potential
  • Catalog Antibodies - The Largest Market Segment
  • Custom Antibodies: Finding Favor in Research Applications
  • Primary Antibodies Dominate the Market
  • Competitive Scenario
  • Immunochemicals - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
  • Abcam Plc. (UK)
  • Agilent Research Laboratories (USA)
  • Biolegend, Inc. (USA)
  • Bio-Rad Laboratories, Inc. (USA)
  • Cell Signaling Technology, Inc. (USA)
  • GenScript Biotech Corporation
  • PerkinElmer, Inc. (USA)
  • Rockland Immunochemicals, Inc. (USA)
  • Santa Cruz Biotechnology, Inc. (USA)
  • Merck (Sigma-Aldrich Corporation) (USA)
  • Thermo Fisher Scientific Inc. (USA)
3. MARKET TRENDS & DRIVERS
  • Increasing Research Funding Bolsters Market Growth
  • Chinese Market to Become the Largest Investor in Basic Research
  • Cancer Research Drives the Global Immunochemicals Market
  • Cancer Ranks Among the Top Ten Causes of Death Worldwide
  • ‘Reproducibility Crisis’ of Antibodies - A Major Cause of Concern
  • Proper Validation of Antibodies - Vendor Do their Part
  • New Technologies for Antibodies Validation
  • Personalized Medicine Offers New Growth Avenues
  • Rabbit Monoclonal Antibodies Score over Other Animal Antibodies
  • Researchers Prefer Commercial Research to Academic Research
  • Increasing Collaborations between Industry and Academia
  • Beckman Coulter GmbH (USA)
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Immunochemicals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 2: World Historic Review for Immunochemicals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 3: World 18-Year Perspective for Immunochemicals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2023 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Catalog Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 5: World Historic Review for Catalog Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 6: World 18-Year Perspective for Catalog Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Custom Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 8: World Historic Review for Custom Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 9: World 18-Year Perspective for Custom Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
  • Table 10: World Immunochemicals Market Analysis of Annual Sales in US$ Million for Years 2012 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Immunochemicals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 11: USA Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 12: USA Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 13: USA 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
CANADA
  • Table 14: Canada Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 15: Canada Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 16: Canada 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
JAPAN
  • Immunochemicals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 17: Japan Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 18: Japan Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 19: Japan 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
CHINA
  • Immunochemicals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 20: China Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 21: China Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 22: China 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
EUROPE
  • Immunochemicals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 23: Europe Recent Past, Current & Future Analysis for Immunochemicals by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 24: Europe Historic Review for Immunochemicals by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 25: Europe 18-Year Perspective for Immunochemicals by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2023 & 2030
  • Table 26: Europe Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 27: Europe Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 28: Europe 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
FRANCE
  • Immunochemicals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 29: France Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 30: France Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 31: France 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
GERMANY
  • Immunochemicals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 32: Germany Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 33: Germany Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 34: Germany 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
ITALY
  • Table 35: Italy Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 36: Italy Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 37: Italy 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
UNITED KINGDOM
  • Immunochemicals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 38: UK Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 39: UK Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 40: UK 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
REST OF EUROPE
  • Table 41: Rest of Europe Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 42: Rest of Europe Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 43: Rest of Europe 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
ASIA-PACIFIC
  • Immunochemicals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 44: Asia-Pacific Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 45: Asia-Pacific Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 46: Asia-Pacific 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
REST OF WORLD
  • Table 47: Rest of World Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 48: Rest of World Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 49: Rest of World 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abcam Plc.
  • Agilent Research Laboratories
  • Beckman Coulter GmbH
  • Biolegend Inc.
  • Bio-Rad Laboratories Inc.
  • Cell Signaling Technology Inc.
  • GenScript Biotech Corporation
  • PerkinElmer Inc.
  • Rockland Immunochemicals Inc.
  • Santa Cruz Biotechnology Inc.
  • Sigma-Aldrich Corporation
  • Thermo Fischer Scientific Inc.

Table Information